These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21518955)

  • 1. Distinct properties of human HMGN5 reveal a rapidly evolving but functionally conserved nucleosome binding protein.
    Malicet C; Rochman M; Postnikov Y; Bustin M
    Mol Cell Biol; 2011 Jul; 31(13):2742-55. PubMed ID: 21518955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function.
    Rochman M; Malicet C; Bustin M
    Biochim Biophys Acta; 2010; 1799(1-2):86-92. PubMed ID: 20123071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of NSBP1/HMGN5 with nucleosomes in euchromatin counteracts linker histone-mediated chromatin compaction and modulates transcription.
    Rochman M; Postnikov Y; Correll S; Malicet C; Wincovitch S; Karpova TS; McNally JG; Wu X; Bubunenko NA; Grigoryev S; Bustin M
    Mol Cell; 2009 Sep; 35(5):642-56. PubMed ID: 19748358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization.
    Zhang S; Schones DE; Malicet C; Rochman M; Zhou M; Foisner R; Bustin M
    J Biol Chem; 2013 Jun; 288(25):18104-9. PubMed ID: 23673662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics reveals a role for the chromatin-binding protein HMGN5 in glutathione metabolism.
    Ciappio ED; Krausz KW; Rochman M; Furusawa T; Bonzo JA; Tessarollo L; Gonzalez FJ; Bustin M
    PLoS One; 2014; 9(1):e84583. PubMed ID: 24392144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opposite Effects of Histone H1 and HMGN5 Protein on Distant Interactions in Chromatin].
    Nizovtseva EV; Polikanov YS; Kulaeva OI; Clauvelin N; Postnikov YV; Olson WK; Studitsky VM
    Mol Biol (Mosk); 2019; 53(6):1038-1048. PubMed ID: 31876282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
    Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
    Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
    Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
    Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.
    Ma Q; Wang X; Wang H; Song W; Wang Q; Wang J
    Biomed Res Int; 2020; 2020():8610271. PubMed ID: 32596388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Liu X; Ma W; Yan Y; Wu S
    J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.
    Zhang XY; Guo ZQ; Ji SQ; Zhang M; Jiang N; Li XS; Zhou LQ
    Asian J Androl; 2012 May; 14(3):487-92. PubMed ID: 22504871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGN5: a potential oncogene in gliomas.
    Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
    J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and Temporal Expression of High-Mobility-Group Nucleosome-Binding (HMGN) Genes in Brain Areas Associated with Cognition in Individuals with Down Syndrome.
    Rodríguez-Ortiz A; Montoya-Villegas JC; García-Vallejo F; Mina-Paz Y
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
    Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
    Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells.
    Chen P; Wang XL; Ma ZS; Xu Z; Jia B; Ren J; Hu YX; Zhang QH; Ma TG; Yan BD; Yan QZ; Li YL; Li Z; Yu JY; Gao R; Fan N; Li B; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(7):3223-8. PubMed ID: 22994738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research advances in HMGN5 and cancer.
    Shi Z; Tang R; Wu D; Sun X
    Tumour Biol; 2016 Feb; 37(2):1531-9. PubMed ID: 26700674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of chromatin structure and function by HMGN proteins.
    Postnikov Y; Bustin M
    Biochim Biophys Acta; 2010; 1799(1-2):62-8. PubMed ID: 19948260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
    He J; Liu C; Wang B; Li N; Zuo G; Gao D
    Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.
    Zhu GJ; Liu F; Xu YG; Zhao CX; Zhao JG; Sun C
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1330-1338. PubMed ID: 33629303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between histone H1 and HMGN proteins for chromatin binding sites.
    Catez F; Brown DT; Misteli T; Bustin M
    EMBO Rep; 2002 Aug; 3(8):760-6. PubMed ID: 12151335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.